Highline Medical Oncology

Burien, Washington 98166

0 studies enrolling now · 12 studies all time

What they study most

Androgen-independent Prostate Cancer, Breast Cancer, Carcinoma, Non-Small Cell Lung, Lung Cancer, Metastatic Breast Cancer, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma, Prostate Cancer, Rectal Cancer, Urothelial Cancer

Studies at this site

• TAC Versus TC for Adjuvant Breast Cancer — Completed
• Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC — Completed
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer — Stopped early
• Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes — Completed
• Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) — Completed
• Ixabepilone + Carboplatin Metastatic Breast Cancer — Completed
• Adj TC + Herceptin Early Stage Breast Cancer — Completed
• Pre-op Rectal ChemoRad +/- Cetuximab — Completed
• Gemzar, Cisp, Sunitinib Urothelial Ca — Completed
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early